JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
Dawson Geophysical
DWSN
$69.6M
| $1K | ﹤0.01% |
263
-6,364
| -96% | -$24.8K |
2016 Q4
3 quarters
|
|
4702
iShares MSCI Switzerland ETF
EWL
$2.82B
| $1K | ﹤0.01% |
41
| – | – |
2013 Q2
17 quarters
|
|
4703
EyePoint Inc
EYPT
$271M
| $1K | ﹤0.01% |
80
-2,104
| -96% | -$26.9K |
2016 Q4
3 quarters
|
|
4704
Global Net Lease
GNL
$1.72B
| $1K | ﹤0.01% |
23
-16,491
| -100% | -$357K |
2016 Q4
3 quarters
|
|
4705
James Hardie Industries
JHX
$15B
| $1K | ﹤0.01% |
110
-388
| -78% | -$5.66K |
2015 Q1
10 quarters
|
|
4706
Kelly Services Class B
KELYB
$785M
| $1K | ﹤0.01% |
62
| – | – |
2013 Q2
17 quarters
|
|
4707
LifeVantage
LFVN
$75.5M
| $1K | ﹤0.01% |
220
-6,962
| -97% | -$27.3K |
2016 Q4
3 quarters
|
|
4708
Decoy Therapeutics
DCOY
$806K
| – | – |
0
| – | – |
2015 Q1
10 quarters
|
|
|
SOL
4709
DELISTED
Emeren Group
SOL
| $1K | ﹤0.01% |
358
| – | – |
2015 Q4
7 quarters
|
|
4710
Spyre Therapeutics
SYRE
$7.49B
| $1K | ﹤0.01% |
8
-43
| -84% | -$4.03K |
2017 Q2
1 quarter
|
|
4711
Alaunos Therapeutics
TCRT
$5.54M
| $1K | ﹤0.01% |
1
| – | – |
2016 Q4
3 quarters
|
|
|
TURN
4712
DELISTED
180 Degree Capital
TURN
| $1K | ﹤0.01% |
167
| – | – |
2016 Q4
3 quarters
|
|
4713
Urban One Class D
UONEK
$17.7M
| $1K | ﹤0.01% |
74
| – | – |
2016 Q2
5 quarters
|
|
4714
Invesco Bond Fund
VBF
$164M
| $1K | ﹤0.01% |
+42
| New | +$822 |
2017 Q3
0 quarters
|
|
4715
Vanguard Long-Term Treasury ETF
VGLT
$10.7B
| $1K | ﹤0.01% |
15
| – | – |
2017 Q2
1 quarter
|
|
4716
Vince Holding Corp
VNCE
$173M
| $1K | ﹤0.01% |
197
| – | – |
2015 Q4
7 quarters
|
|
4717
Tortoise Global Water ETF
TBLU
$55.7M
| $1K | ﹤0.01% |
25
| – | – |
2017 Q2
1 quarter
|
|
4718
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
4719
DELISTED
Bio-Path Holdings Inc
BPTH
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
|
CGRN
4720
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1K | ﹤0.01% |
135
| – | – |
2014 Q2
13 quarters
|
|
|
AMPE
4721
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $1K | ﹤0.01% |
6
| – | – |
2017 Q2
1 quarter
|
|
|
EIGI
4722
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $1K | ﹤0.01% |
191
| – | – |
2016 Q4
3 quarters
|
|
|
PSV
4723
DELISTED
Hermitage Offshore Services Ltd.
PSV
| $1K | ﹤0.01% |
60
+59
| +5,900% | +$756 |
2015 Q4
7 quarters
|
|
|
FOMX
4724
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1K | ﹤0.01% |
217
-11,589
| -98% | -$59.9K |
2017 Q2
1 quarter
|
|
|
CHKR
4725
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
| $1K | ﹤0.01% |
250
| – | – |
2016 Q2
5 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.